Life Sciences IT Services and Digital Solutions · NSE · period ending 2026-03-31
Loading chart…
✓ Core business is permissible and non-compliant income is 0.38% of revenue (limit 5%).
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Debt / 36-month avg market cap | 0.02% | < 33% | Pass |
| Cash + interest-bearing securities / 36-month avg market cap | 13.49% | < 33% | Pass |
| Accounts receivable / 36-month avg market cap | 0% | < 33% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up free0.38% of any dividend from INDGN should be given to charity. Calculate your amount →
Compliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.
Slightly positive 3-month returns but negative 1- and 6-month performance, with price well below the 52-week high and 50-day under 200-day, point to a weak range-to-drift environment. No mapped sector sentiment is included, so the backdrop is described as neutral.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.